ZA973961B - Crystalline(-)3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane, hydrogen fumarate. - Google Patents

Crystalline(-)3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane, hydrogen fumarate.

Info

Publication number
ZA973961B
ZA973961B ZA9703961A ZA973961A ZA973961B ZA 973961 B ZA973961 B ZA 973961B ZA 9703961 A ZA9703961 A ZA 9703961A ZA 973961 A ZA973961 A ZA 973961A ZA 973961 B ZA973961 B ZA 973961B
Authority
ZA
South Africa
Prior art keywords
phenyl
chromane
ethoxy
trans
methoxy
Prior art date
Application number
ZA9703961A
Other languages
English (en)
Inventor
Svend Treppendahl
Klaus Snej Jensen
Scott E Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA973961B publication Critical patent/ZA973961B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9703961A 1996-05-08 1997-05-08 Crystalline(-)3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane, hydrogen fumarate. ZA973961B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK55296 1996-05-08

Publications (1)

Publication Number Publication Date
ZA973961B true ZA973961B (en) 1997-12-04

Family

ID=8094838

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9703961A ZA973961B (en) 1996-05-08 1997-05-08 Crystalline(-)3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane, hydrogen fumarate.

Country Status (17)

Country Link
EP (1) EP0912543B1 (de)
JP (1) JP2951410B2 (de)
KR (1) KR20000010644A (de)
CN (1) CN1218462A (de)
AT (1) ATE262516T1 (de)
AU (1) AU710334B2 (de)
BR (1) BR9709060A (de)
CA (1) CA2253284A1 (de)
CZ (1) CZ359898A3 (de)
DE (1) DE69728271D1 (de)
HU (1) HUP9901738A3 (de)
IL (1) IL126345A (de)
NO (1) NO985205D0 (de)
PL (1) PL329624A1 (de)
RU (1) RU2182149C2 (de)
WO (1) WO1997042184A1 (de)
ZA (1) ZA973961B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104166678B (zh) * 2014-07-09 2018-04-10 苏州市职业大学 一种面向汉语微博的多种潜在属性整体挖掘系统及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives
GB9301611D0 (en) * 1993-08-04 1993-08-04 Parisella Gerald Dexterity game
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
ATE262516T1 (de) 2004-04-15
BR9709060A (pt) 1999-08-03
NO985205L (no) 1998-11-06
JPH11501953A (ja) 1999-02-16
IL126345A0 (en) 1999-05-09
AU710334B2 (en) 1999-09-16
KR20000010644A (ko) 2000-02-25
AU2763897A (en) 1997-11-26
CZ359898A3 (cs) 1999-05-12
CN1218462A (zh) 1999-06-02
PL329624A1 (en) 1999-03-29
DE69728271D1 (en) 2004-04-29
HUP9901738A3 (en) 2000-12-28
JP2951410B2 (ja) 1999-09-20
HUP9901738A2 (en) 2000-07-28
CA2253284A1 (en) 1997-11-13
RU2182149C2 (ru) 2002-05-10
EP0912543B1 (de) 2004-03-24
WO1997042184A1 (en) 1997-11-13
EP0912543A1 (de) 1999-05-06
IL126345A (en) 2001-07-24
NO985205D0 (no) 1998-11-06

Similar Documents

Publication Publication Date Title
AU3366297A (en) Polymorphic compounds
BG101833A (bg) Гуаниново производно
AU3631197A (en) N-benzylpiperidine and tetrahydropyridine derivatives
CA2236673A1 (en) (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
HU9802143D0 (en) New heterocyclic compounds of 5 members in the ring, process for producing them and pharmaceutical compositions containing them
ZA973961B (en) Crystalline(-)3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)chromane, hydrogen fumarate.
NZ332545A (de)
AU8631698A (en) A process for the preparation of tetraazamacrocycles
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
ZA200005110B (en) Process for preparing intermediates.
AU2001277801A1 (en) Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols
UA66859C2 (uk) Спосіб стереохімічно контрольованого одержання ізомерно чистих високозаміщених азациклічних сполук
MXPA01005769A (es) Nuevas formas cristalinas del acido (3s-trans) -2[3,4-dihidro -4-hidroxi -3-(enilmetil)-2h -1-benzofiran -7-il] -4- (trifluorometil) benzoico.
AU6086998A (en) Process for preparing 1,4-disubstituted piperidine compounds
AU4595100A (en) ((e),3(r))-enantiomer of 4-(3-chloro -4-cyanophenyl) -1-(p- methylsulphonyl -phenylsulphonyl) -2-trifluoromethylbut -trans-3-en-ol
AU1570300A (en) Method for preparing (r)- (+) -3 (1- (2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl)- 4-phenylpiperidin -4-yl)-1,1- dimethylurea, its salts solvates and/or hydrates
AU5668698A (en) Method for preparing a tetrahydropyridin derivative
AU2000246281A1 (en) Piperidine compounds and process for providing such
GB0021147D0 (en) Chemical process
AU5618699A (en) N-substituted azabicycloheptane derivatives, production and use thereof
BG101431A (en) the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR
NO20012028L (no) Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler